scholarly journals Early psychosocial intervention in Alzheimer's disease: cost utility evaluation alongside the Danish Alzheimer's Intervention Study (DAISY)

BMJ Open ◽  
2014 ◽  
Vol 4 (1) ◽  
pp. e004105 ◽  
Author(s):  
Rikke Søgaard ◽  
Jan Sørensen ◽  
Frans B Waldorff ◽  
Ane Eckermann ◽  
Dorte V Buss ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Psychosocial Intervention ◽  
Intervention Study ◽  
Cost Utility ◽  
Disease Cost ◽  
Utility Evaluation

scholarly journals Efficacy of psychosocial intervention in patients with mild Alzheimer's disease: the multicentre, rater blinded, randomised Danish Alzheimer Intervention Study (DAISY)

BMJ ◽  
2012 ◽  
Vol 345 (jul17 1) ◽  
pp. e4693-e4693 ◽  
Author(s):  
F. B. Waldorff ◽  
D. V. Buss ◽  
A. Eckermann ◽  
M. L. H. Rasmussen ◽  
N. Keiding ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Psychosocial Intervention ◽  
Intervention Study

The cost-utility of the rivastigmine transdermal patch in the management of patients with moderate Alzheimer's disease in the US

2009 ◽  
Vol 36 (S 02) ◽  
Author(s):  
A Brennan ◽  
B Nagy ◽  
A Brandtmüller ◽  
SK Thomas ◽  
M Gallagher ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cost Utility ◽  
Transdermal Patch ◽  
The Us ◽  
The Cost

P3-279: THE IMPACT OF MAJOR DEPRESSION IN PATIENTS NEWLY DIAGNOSED WITH MILD ALZHEIMER'S DISEASE: THE DANISH ALZHEIMER'S DISEASE INTERVENTION STUDY (DAISY)

2014 ◽  
Vol 10 ◽  
pp. P733-P734
Author(s):  
Frans Boch Waldorff ◽  
Thien Kieu Thi Phung ◽  
Anna Carina Klara Magdalena Bebe ◽  
Tora Grauers Willadsen ◽  
Volkert Siersma ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Major Depression ◽  
Intervention Study ◽  
Newly Diagnosed ◽  
The Impact

scholarly journals PND15 THE COST-UTILITY OF EXELON PATCH IN THE MANAGEMENT OF PATIENTS WITH MODERATE ALZHEIMER'S DISEASE IN THE UNITED KINGDOM

2007 ◽  
Vol 10 (6) ◽  
pp. A384 ◽  
Author(s):  
A Brennan ◽  
B Nagy ◽  
A Brandtmuller ◽  
SK Thomas ◽  
SD Sullivan ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
United Kingdom ◽  
Cost Utility ◽  
The United Kingdom ◽  
The Cost

scholarly journals Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a mapping study

2020 ◽  
Author(s):  
Ines Rombach ◽  
◽  
Marvi Iftikhar ◽  
Gurleen S. Jhuti ◽  
Anders Gustavsson ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Model Performance ◽  
Absolute Error ◽  
Cost Utility ◽  
Multinomial Regression ◽  
Mapping Algorithm ◽  
Disease Specific

Abstract Purpose The Quality of Life Alzheimer’s Disease Scale (QoL-AD) is commonly used to assess disease specific health-related quality of life (HRQoL) as rated by patients and their carers. For cost-effectiveness analyses, utilities based on the EQ-5D are often required. We report a new mapping algorithm to obtain EQ-5D indices when only QoL-AD data are available. Methods Different statistical models to estimate utility directly, or responses to individual EQ-5D questions (response mapping) from QoL-AD, were trialled for patient-rated and proxy-rated questionnaires. Model performance was assessed by root mean square error and mean absolute error. Results The response model using multinomial regression including age and sex, performed best in both the estimation dataset and an independent dataset. Conclusions The recommended mapping algorithm allows researchers for the first time to estimate EQ-5D values from QoL-AD data, enabling cost-utility analyses using datasets where the QoL-AD but no utility measures were collected.

Sign in / Sign up

Export Citation Format

Share Document